Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03223636 · ClinicalTrials.gov registry record

Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological Techniques

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
16
Enrollment target

NCT03223636 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03223636 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
16 participants
Enrollment target

Study Summary

Background: Little is known about the time it takes for nerve signals to go from one area of the brain to another. Using advanced methods for brain research, researchers want to look at the time it takes to send messages between different brain areas. They also want to develop new tests. Objectives: To develop tests to measure the sizes of nerve fibers in the peripheral nerve system and in the brain. Also to find out the different speeds that information travels in nerve fibers. Eligibility: Healthy, right-handed people ages 18-70 Design: Participants will be screened with medical history and a physical exam. Participants will have up to 7 visits depending on the tests they choose. Visits last about 2-4 hours and may involve the following tests: * Physical exam * Urine tests * Magnetic resonance imaging (MRI). Participants lie on a table that slides into a scanner. They will be in the scanner for up to 1 hour. For some scans, sensors are placed on the skin. They will get earplugs for loud noises. * Small, sticky pads on the skin will electrically stimulate nerves in the forearm. * Transcranial magnetic stimulation (TMS). A wire coil will be held to the scalp. A brief electrical current passes through the coil to affect brain activity. * Electroencephalography. TMS will be given to the brain. Small electrodes on the scalp measure brain activity. Participants may do small tasks. * Electrodes on the scalp will send an electrical current to the brain. * A cone with magnetic detectors will be lowered onto the head to record brain activity. Participants will perform various tasks.

Interventions

  • DEVICE TMS
  • DEVICE MRI

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-10-02
Est. Completion 2021-02-26

What the Registry Record Tells You About NCT03223636

The ClinicalTrials.gov registry entry for NCT03223636 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which TMS is the first listed.

NCT03223636 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03223636 about?

NCT03223636 is a clinical study titled "Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological Techniques". Background: Little is known about the time it takes for nerve signals to go from one area of the brain to another. Using advanced methods for brain research, researchers want to look at the time it takes to send messages between different brain areas. They also want to develop new tests. Objective...

What is the current status of trial NCT03223636?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2017-10-02. Estimated completion is 2021-02-26.

What interventions are being tested in trial NCT03223636?

The interventions under investigation include: TMS (DEVICE), MRI (DEVICE).

Who is sponsoring clinical trial NCT03223636?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.